Gilead Sciences (United Kingdom)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (United Kingdom), United Kingdom, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
62%
Total
Publications
437
Total Open
Publications
271
Total
Citations
8.9K
Open Access
Percentage
62%
Total
Publications
437
Total Open
Publications
271
Total
Citations
8.9K
Breakdown
Publisher Open
25%
Both
31%
Other Platform Open
6%
Closed
38%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 41%
101
Hybrid 27%
67
No Guarantees 32%
77
Other Platform Open
Domain 83%
133
Institution 53%
86
Preprint 6%
10
Other Internet 6%
10
Public 2%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 137 |
doaj.org OAI-PMH Repository | Institution | 45 |
University of Groningen | Institution | 8 |
University of Bristol | Institution | 8 |
Unknown Repository | Other Internet | 6 |
DOI | Other Internet | 5 |
University of Milano-Bicocca | Institution | 4 |
medRxiv | Preprint | 4 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 4 |
University of Oxford | Institution | 3 |